HIV-1 CRF 02 AG polymerase genes in Southern Ghana are mosaics of different 02 AG strains and the protease gene cannot infer subtypes

BackgroundLittle is known about the detailed phylogeny relationships of CRF 02_AG HIV-1 polymerase genes in Ghana. The use of the protease gene of HIV-1 for subtyping has shown conflicting results.MethodsThe partial polymerase gene sequences of 25 HIV-1 strains obtained with Viroseq reagents were aligned with reference subtypes and alignments trimmed to a 300 bp protease, 661 bp and 1005 reverse transcriptase sequence alignments. Phylogenetic relationships of these alignments were determined with the Neighbour-Joining method using 1000 replicates and recombination patterns determined for the sequences with RIP 3.0 in the HIV sequence database.ResultsUnlike the other alignments, the protease gene had nodes with bootstrap values < 100% for repeat control sequences. Majority of the CRF 02_AG sequences from Ghana were made up of fragments of several strains of CRF 02_AG/AG strains. The protease gene alone is not suitable for phylogenetic analysis.ConclusionThe polymerase genes of HIV-1 strains from Ghana are made up of recombinants of several CRF 02_AG strains from Ghana, Senegal and Cameroon, but the clinical implications are unknown. Using the HIV-1 protease gene for subtyping will not infer subtypes correctly.

[1]  H Hui,et al.  The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin , 1996, Journal of virology.

[2]  M. Peeters,et al.  Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K. , 2000, AIDS research and human retroviruses.

[3]  F. Lucht,et al.  Analysis of Polymorphism in the Protease and Reverse Transcriptase Genes of HIV Type 1 CRF02-AG Subtypes From Drug-Naive Patients From Saint-Etienne, France , 2006, Journal of acquired immune deficiency syndromes.

[4]  C. Pasquier,et al.  HIV-1 subtyping using phylogenetic analysis of pol gene sequences. , 2001, Journal of virological methods.

[5]  T. Sata,et al.  HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  M. Kalish,et al.  Human Immunodeficiency Virus Type 1 Group M Protease in Cameroon: Genetic Diversity and Protease Inhibitor Mutational Features , 2002, Journal of Clinical Microbiology.

[7]  Isaac Boamah,et al.  Variability of the human immunodeficiency virus type 1 polymerase gene from treatment naïve patients in Accra, Ghana. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[8]  E. Paxinos,et al.  Genotypic and phenotypic analyses of human immunodeficiency virus type 1 in antiretroviral drug-naive Nigerian patients. , 2006, AIDS research and human retroviruses.

[9]  R. Grant,et al.  Dehydroepiandrosterone (DHEA) effects on HIV replication and host immunity: a randomized placebo-controlled study. , 2007, AIDS research and human retroviruses.

[10]  G. Learn,et al.  HIV-1 Nomenclature Proposal , 2000, Science.

[11]  D. Gotte,et al.  Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants. , 1998, Virology.

[12]  B. Coulibaly,et al.  Diversity of HIV in Rural Burkina Faso , 2006, Journal of acquired immune deficiency syndromes.

[13]  L. Morris,et al.  Phenotypic characterization of HIV type 1 isolates from Ghana. , 2007, AIDS research and human retroviruses.

[14]  M. Peeters,et al.  Most env and gag Subtype A HIV‐1 Viruses Circulating in West and West Central Africa Are Similar to the Prototype AG Recombinant Virus IBNG , 2000, Journal of acquired immune deficiency syndromes.

[15]  F. Brun-Vézinet,et al.  Identification of a new human immunodeficiency virus type 1 distinct from group M and group O , 1998, Nature Medicine.

[16]  M. Kimura.  A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences , 1980, Journal of Molecular Evolution.

[17]  F. Ceccherini‐Silberstein,et al.  Characterization of drug‐resistance mutations in HIV‐1 isolates from non‐HAART and HAART treated patients in Burkina Faso , 2006, Journal of medical virology.

[18]  Stéphane Hué,et al.  HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy , 2004, AIDS.

[19]  Helen H. Lee,et al.  Molecular epidemiology of HIV in Ghana: Dominance of CRF02_AG , 2004, Journal of medical virology.

[20]  K. Mandaliya,et al.  A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance. , 2006, Journal of virological methods.

[21]  A. Tanuri,et al.  Genetic Variability of HIV-1 Protease from Nigeria and Correlation with Protease Inhibitors Drug Resistance , 2001, Virus Genes.

[22]  C. Pasquier,et al.  Assessment of HIV-1 subtyping for Cameroon strains using phylogenetic analysis of pol gene sequences. , 2003, Journal of virological methods.

[23]  M. Thomson,et al.  Identification of a Novel HIV-1 Circulating ADG Intersubtype Recombinant Form (CRF19_cpx) in Cuba , 2005, Journal of acquired immune deficiency syndromes.

[24]  C. Brennan,et al.  Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for Sequence-Based Analysis of Diverse Human Immunodeficiency Virus Type 1 Strains , 2004, Journal of Clinical Microbiology.